Biopuremax

Pharmaceutical Pretreatment Water Systems

Industrial Technologies
Private

Company Overview

Snapshot

Founded in August 2015 by Shlomo Sackstein and Eric Shem-Tov, Biopuremax operates with 11–50 employees. The company specializes in advanced water treatment systems for the biopharmaceutical industry. In July 2019, the company was noted for its adherence to the new ISO 22519 PW/WFI production standard, highlighting its commitment to regulatory compliance and quality in water purification.

Business overview

Biopuremax provides standardized package systems for supplying chemical-free and media-free water as reverse osmosis (RO) feed water, primarily for the pharmaceutical industry. The company designs, installs, and commissions water systems, including pretreatment, purified water (PW), and water-for-injection (WFI) systems. Utilizing technologies such as reverse osmosis, continuous electro de-ionization (CEDI), and ultrafiltration (UF, the company serves the biopharmaceutical market with compact, reliable, and low-maintenance solutions that meet international standards.

Strategic signal

In July 2019, Biopuremax's alignment with the new ISO 22519 PW/WFI production standard signaled its commitment to high-quality and compliant water treatment solutions. This adherence is critical for pharmaceutical clients, demonstrating the company's capability to meet stringent industry regulations and reinforcing its position as a reliable provider in the biopharmaceutical water treatment sector.

Company Intelligence Q&A

What is Biopuremax's primary focus?
Biopuremax focuses on providing standardized package systems for chemical-free and media-free water, specifically for reverse osmosis feed water in the pharmaceutical industry.
When was Biopuremax founded?
Biopuremax was founded in August 2015.
Who are the founders of Biopuremax?
Biopuremax was co-founded by Shlomo Sackstein and Eric Shem-Tov.
What technologies does Biopuremax utilize in its water treatment systems?
Biopuremax utilizes technologies such as reverse osmosis, continuous electro de-ionization (CEDI), and ultrafiltration (UF) for biopharmaceutical water treatment.
What significant industry standard did Biopuremax align with in 2019?
In July 2019, Biopuremax aligned with the new ISO 22519 PW/WFI production standard, emphasizing its commitment to regulatory compliance in water purification.